Avian influenza severely affects the supply situation of animal protein if it is not controlled. A number of cases have reminded humankind in the recent past that avian influenza is not only a threat to animals, but to humans as well.

Preventive vaccination of the animals is one approach to controlling the disease. At its R&D and production site in Guadalajara, Mexico, Boehringer Ingelheim Animal Health has successfully developed and is producing two different vaccines, which are contributing to the control of avian influenza in countries such as Mexico and Egypt.

Solutions for poultry

Volvac^® is the umbrella brand of the Boehringer Ingelheim Animal Health poultry vaccine range. It consists of a wide range of live and inactivated vaccines for broilers and layers. The vaccines provide protection of the birds against various viral and bacterial diseases like avian influenza, infectious bronchitis, Newcastle disease, infectious bursal disease, egg drop syndrome and avian coryza. The Volvac^® vaccines also allow the birds to express their full potential, and increase their well-being.

Indication	Brand Name	Active Ingredient
Various viral and bacterial diseases in poultry	Volvac®	polyvalent attenuated live and inactivated vaccine containing antigens for vaccination against avian influenza, Newcastle disease, avian coryza, egg drop syndrome, infectious bronchitis, infectious bursal disease, bacterium anatis	For vaccination of healthy chickens against diseases caused by the included antigens. For the most common diseases responsible for losses in egg production in layers and affecting the health of broiler chickens.